Race Oncology Ltd. (AU:RAC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Race Oncology Ltd. has announced a change in director Dr. Sergio Scrofani’s interest, with the acquisition of 58,446 unlisted options. These options are exercisable at $2.05 and will expire on November 25, 2028, following shareholder approval. This move may interest investors tracking executive decisions within the company.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.